Accessibility Menu
Stryker Stock Quote

Stryker (NYSE: SYK)

$379.92
(-0.3%)
-1.30
Price as of October 21, 2025, 3:58 p.m. ET

KEY DATA POINTS

Current Price
$379.76
Daily Change
(-0.3%) $1.30
Day's Range
$377.24 - $383.12
Previous Close
$379.76
Open
$381.22
Beta
0.89
Volume
122
Average Volume
1,319,266
Market Cap
145.2B
Market Cap / Employee
$379.76M
52wk Range
$329.16 - $406.19
Revenue
-
Gross Margin
0.62%
Dividend Yield
0.88%
EPS
$7.56
CAPs Rating
-
Industry
Healthcare Equipment and Supplies

The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More

Stryker Return vs. S&P

1 Year5 Year5 Year AnnualizedSince IPO
SYK+4.35%+78.03%+12.23%+90,122%
S&P+15.06%+95.03%+14.29%+3,850%

Stryker Company Info

Stryker Corp. is a medical technology company, which engages in the provision of innovative products and services that help improve patient and healthcare outcomes. It operates under the MedSurg and Neurotechnology, and Orthopaedics and Spine segments. The MedSurg and Neurotechnology segment includes surgical equipment and navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment, intensive care disposable products, clinical communication, workflow solutions, products for the treatment of acute ischemic and hemorrhagic stroke, traditional brain, and open skull based surgical procedures, orthobiologic, and biosurgery. The Orthopaedics and Spine segment focuses on implants used in hip and knee joint replacements and trauma and extremity surgeries, and cervical, thoracolumbar, and interbody systems used in spinal injury, deformity, and degenerative therapies. The company was founded by Homer H. Stryker in 1941 and is headquartered in Kalamazoo, MI.

News & Analysis

The Fool has written over 200 articles on Stryker.

Financial Health

General

Q2 2025YOY Change
Revenue$6.02B11.1%
Gross Profit$3.75B12.8%
Gross Margin62.27%1.0%
Market Cap$151.20B16.6%
Market Cap / Employee$2.85M0.0%
Employees53K1.9%
Net Income$884.00M7.2%
EBITDA$1.66B17.0%

Currently no data to display

Revenue Growth Rate

Currently no data to display.

Earnings Per Share Growth Rate

Currently no data to display.

Assets

Q2 2025YOY Change
Net Cash$2.38B26.7%
Accounts Receivable$3.92B8.2%
Inventory5.3K4.9%

Liabilities

Q2 2025YOY Change
Long Term Debt$15.22B44.9%
Short Term Debt$1.91B-14.7%

Ratios

Q2 2025YOY Change
Return On Assets6.83%-2.2%
Return On Invested Capital8.20%0.0%

Cash Flow

Q2 2025YOY Change
Free Cash Flow$928.00M92.9%
Operating Free Cash Flow$1.11B75.5%

Valuation

MetricQ3 2024Q4 2024Q1 2025Q2 2025YoY Change
Price to Earnings38.7346.3850.2352.3537.96%
Price to Book6.976.816.887.226.85%
Price to Sales6.346.156.206.424.69%
Price to Tangible Book Value-15297.35-115.63369.73-35.23-81.30%
Price to Free Cash Flow TTM69.4461.2961.4255.13-31.73%
Enterprise Value to EBITDA102.0577.14109.43101.110.88%
Free Cash Flow Yield1.4%1.6%1.6%1.8%46.47%
Return on Equity18.9%15.3%14.3%14.3%-23.29%
Total Debt$16.01B$14.12B$17.36B$17.13B34.40%

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.